balance equationreview2016-12-31
Difference 3918000 exceeds tolerance 1396151.000. Presentation or filing-vintage differences need review.
Revenue
$4.03B
Fiscal year ended 2025-12-31Operating income
$545.76M
Fiscal year ended 2025-12-31Free cash flow
$490.78M
Fiscal year ended 2025-12-31ALIGN TECHNOLOGY INC (ALGN) reported revenue of $4.03B and net income of $410.35M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ALIGN TECHNOLOGY INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B |
| Cost of revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $708.71M | $662.90M | $518.62M | $356.47M | $264.58M |
| Gross profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815.29M |
| Operating income | $545.76M | $607.63M | $643.34M | $642.60M | $976.40M | $387.17M | $542.49M | $466.56M | $353.61M | $248.92M |
| Net income | $410.35M | $421.36M | $445.05M | $361.57M | $772.02M | $1.78B | $442.78M | $400.24M | $231.42M | $189.68M |
| Research & development | $369.91M | $364.20M | $346.83M | $305.26M | $250.32M | $175.31M | $157.36M | $128.90M | $97.56M | $75.72M |
| Weighted-average diluted shares | shares 72.59M | shares 74.99M | shares 76.57M | shares 78.42M | shares 79.67M | shares 79.23M | shares 80.10M | shares 81.36M | shares 81.83M | shares 81.48M |
| Pretax income | $585.29M | $608.96M | $641.20M | $599.06M | $1.01B | $378.95M | $562.65M | $466.65M | $364.80M | $242.57M |
| Income tax expense | $174.94M | $187.60M | $196.15M | $237.48M | $240.40M | -$1.40B | $112.35M | $57.72M | $130.16M | $51.20M |
| Diluted EPS | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 |
| Selling, general & administrative | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852.40M | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.07B | $852.40M | $665.78M | $490.65M |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.09B | $1.04B | $937.44M | $942.05M | $1.10B | $960.84M | $550.42M | $636.90M | $449.51M | $389.28M |
| Total assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B |
| Current assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $952.98M |
| Total liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $799.57M | $629.72M | $400.76M |
| Current liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B | $1.33B | $970.97M | $692.07M | $500.05M | $354.34M |
| Total equity incl. NCI | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $999.31M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $226.34M | $254.29M | $296.90M | $338.75M | $230.23M | $139.24M | $112.05M | $55.64M | $31.69M | $27.13M |
| Accounts receivable | $1.10B | $995.68M | $903.42M | $859.68M | $897.20M | $657.70M | $550.29M | $439.01M | $324.19M | $247.42M |
| Goodwill | $491.83M | $442.63M | $419.53M | $407.55M | $418.55M | $444.82M | $63.92M | $64.03M | $64.61M | $61.04M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $121.45M | $108.69M | $113.12M | $127.87M | $163.89M | $142.13M | $87.25M | $64.26M | $36.78M | $28.60M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $593.22M | $738.23M | $785.78M | $568.73M | $1.17B | $662.17M | $747.27M | $554.68M | $438.54M | $247.65M |
| Capital expenditures | $102.44M | $115.58M | $177.72M | $291.90M | $401.10M | $154.92M | $149.71M | $223.31M | $195.70M | $70.58M |
| Investing cash flow | -$112.44M | -$254.91M | -$195.94M | -$213.32M | -$563.43M | -$231.51M | -$350.44M | $6.93M | -$251.48M | $73.03M |
| Financing cash flow | -$464.58M | -$355.72M | -$598.34M | -$501.69M | -$458.33M | -$30.81M | -$485.54M | -$369.43M | -$135.50M | -$95.52M |
| Net change in cash | $51.22M | $106.44M | -$3.84M | -$157.78M | $138.66M | $410.34M | -$86.43M | $187.44M | $57.11M | $221.78M |
| Stock-based compensation | $185.87M | $173.70M | $154.03M | $133.37M | $114.34M | $98.43M | $88.18M | $70.76M | $58.85M | $54.15M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $465.94M | $352.88M | $592.36M | $435.04M | $375.04M | $0 | $400.00M | $300.00M | $103.79M | $96.22M |
| Depreciation & amortization | $237.44M | $145.03M | $142.40M | $125.79M | $108.73M | $93.54M | $78.99M | $54.73M | $37.74M | $24.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $490.78M | $622.65M | $608.06M | $276.83M | $771.45M | $507.26M | $597.56M | $331.37M | $242.84M | $177.08M |
| Gross margin | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% |
| Operating margin | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% |
| FCF margin | 12.2% | 15.6% | 15.7% | 7.4% | 19.5% | 20.5% | 24.8% | 16.9% | 16.5% | 16.4% |
| SBC / revenue | 4.6% | 4.3% | 4.0% | 3.6% | 2.9% | 4.0% | 3.7% | 3.6% | 4.0% | 5.0% |
| Current ratio | 1.36x | 1.22x | 1.18x | 1.26x | 1.30x | 1.40x | 1.68x | 1.88x | 2.32x | 2.69x |
| Revenue YoY growth | 0.9% | 3.5% | 3.4% | -5.5% | 59.9% | 2.7% | 22.4% | 33.5% | 36.4% | Unavailable |
| Net margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.4% | 15.7% | 17.6% |
| R&D / revenue | 9.2% | 9.1% | 9.0% | 8.2% | 6.3% | 7.1% | 6.5% | 6.6% | 6.6% | 7.0% |
| CapEx / revenue | 2.5% | 2.9% | 4.6% | 7.8% | 10.1% | 6.3% | 6.2% | 11.4% | 13.3% | 6.5% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 29.9% | 30.8% | 30.6% | 39.6% | 23.7% | -368.6% | 20.0% | 12.4% | 35.7% | 21.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ALGN in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.